Literature DB >> 29981407

Characterization of a smart pH-cleavable PEG polymer towards the development of dual pH-sensitive liposomes.

Manju Kanamala1, Brian D Palmer2, William R Wilson2, Zimei Wu3.   

Abstract

To facilitate the development of PEG-cleavable pH-sensitive liposomes (CL-pPSL), this study aimed to fully characterize a new pH-sensitive polymer, PEGB-Hz-CHEMS. Polyethylene glycol (PEG) functionalised with 4-carboxybenzaldehyde (PEGB) was linked to cholesteryl hemisuccinate (CHEMS) via an acid labile hydrazide-hydrazone hybrid bond (CONHNCH) to form PEGB-Hz-CHEMS. The polymer was post-inserted into DOPE/CHEMS liposomes to form CL-pPSL. A validated stability-indicating HPLC-UV method was developed with the aid of multiple linear regression for the mobile phase. The assay was used to evaluate the pH-sensitivity, pathways of cleavage of the polymer and the PEGylation degree of CL-pPSL. The pH-sensitivity of CL-pPSL was compared with conventional PEGylated pH-sensitive (pPSL) using a calcein leakage assay. At 37 °C, PEGB-Hz-CHEMS was relatively stable at pH 7.4 with a half-life of 24 h. In comparison, at pH 5.5 and pH 6.5 PEG detachment within 1 h was determined as 80%, and 50%, respectively. PEG detachment of the polymer was through simultaneous cleavage of the hydrazine (CON) and hydrazone (NC) bonds, depending on pH, thus the polymer is more pH-sensitive than those with a hydrazine bond only. The grafting densities of PEGB-Hz-CHEMS on CL-pPSL were optimised to achieve a PEG density of 1.7% (mol). The unilamellar CL-pPSL (123 nm) were shown to be sable at least for 3 months at 4 °C and have enhanced pH-sensitivity compared with pPSL in the calcein leakage assay. Therefore, the smart cleavable PEG polymer is promising in liposome formulation to overcome the PEG dilemma.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cleavable PEG; Dual pH-sensitive liposomes; Hydrazide-hydrazone; Multiple linear regression model; PEG detachment pathway; Stability-indicating HPLC method

Mesh:

Substances:

Year:  2018        PMID: 29981407     DOI: 10.1016/j.ijpharm.2018.07.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

Review 1.  Progress and Principle of Drug Nanocrystals for Tumor Targeted Delivery.

Authors:  Meng Bai; Mingshi Yang; Junbo Gong; Hui Xu; Zhenping Wei
Journal:  AAPS PharmSciTech       Date:  2021-12-28       Impact factor: 3.246

Review 2.  Polymer-Modified Liposomes for Drug Delivery: From Fundamentals to Applications.

Authors:  Yifeng Cao; Xinyan Dong; Xuepeng Chen
Journal:  Pharmaceutics       Date:  2022-04-02       Impact factor: 6.525

3.  Antitumor Effect of Hyperoside Loaded in Charge Reversed and Mitochondria-Targeted Liposomes.

Authors:  Yufei Feng; Guozhao Qin; Shuyuan Chang; Zhongxu Jing; Yanyan Zhang; Yanhong Wang
Journal:  Int J Nanomedicine       Date:  2021-04-28

4.  Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer.

Authors:  Min Woo Kim; Takuro Niidome; Ruda Lee
Journal:  Mar Drugs       Date:  2019-10-12       Impact factor: 5.118

Review 5.  Drug Delivery Systems with a "Tumor-Triggered" Targeting or Intracellular Drug Release Property Based on DePEGylation.

Authors:  Zhe Ren; Tao Liao; Cao Li; Ying Kuang
Journal:  Materials (Basel)       Date:  2022-07-31       Impact factor: 3.748

6.  The pH-Responsive Liposomes-The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells.

Authors:  Eirik A L Rustad; Susannah von Hofsten; Robin Kumar; Eirik A Lænsman; Gerd Berge; Nataša Škalko-Basnet
Journal:  Pharmaceutics       Date:  2022-05-25       Impact factor: 6.525

Review 7.  Polymeric Drug Delivery Systems Bearing Cholesterol Moieties: A Review.

Authors:  Paweł Misiak; Karolina H Markiewicz; Dawid Szymczuk; Agnieszka Z Wilczewska
Journal:  Polymers (Basel)       Date:  2020-11-06       Impact factor: 4.329

8.  Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA.

Authors:  Xixi Hu; Jun Zhang; Lulu Deng; Hao Hu; Junjie Hu; Guohua Zheng
Journal:  AAPS PharmSciTech       Date:  2021-03-10       Impact factor: 3.246

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.